Carecloud, Inc. (CCLD)
NASDAQ:CCLD
Want to see CCLD full AI Analyst Report?
Top Page
CareCloud
(NASDAQ:CCLD)
Select Model
Select Model
Rating:68Neutral
Price Target:
$2.50
▼(-18.57% Downside)
Action:Reiterated
Date:05/10/26
CCLD scores as moderately attractive, led by strong recent financial performance (profitability recovery, low leverage, and solid cash generation) and supportive earnings-call guidance pointing to substantial EPS improvement. These positives are tempered by weak technicals (clear downtrend/negative momentum) and a demanding valuation (high P/E with no dividend support), which together keep the overall score from moving higher.
Positive Factors
Strong cash generation
CareCloud's operating cash flow and trailing free cash flow have strengthened, with FCF roughly matching net income. Reliable cash conversion supports continued investment in product development and integration, reduces the need for dilutive financing, and underpins debt servicing and strategic flexibility over coming months.
Negative Factors
Margin pressure and amortization
Margins have compressed from 2024 into TTM amid higher costs and acquisition-related amortization. Persistent amortization of acquired intangibles and integration expenses can continue to weigh on reported margins and profitability, delaying the expected margin normalization even if revenue growth persists.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
CareCloud's operating cash flow and trailing free cash flow have strengthened, with FCF roughly matching net income. Reliable cash conversion supports continued investment in product development and integration, reduces the need for dilutive financing, and underpins debt servicing and strategic flexibility over coming months.
Read all positive factors
CareCloud (CCLD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$96.88M
Dividend YieldN/A
Average Volume (3M)688.96K
Price to Earnings (P/E)42.0
Beta (1Y)1.92
Revenue Growth10.34%
EPS GrowthN/A
CountryUS
Employees3,650
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.11
Shares Outstanding42,492,950
10 Day Avg. Volume695,278
30 Day Avg. Volume688,955
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)18.55
Price to Sales (P/S)9.16
P/FCF Ratio46.40
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue0.80
Enterprise Value/Gross Profit2.51
Enterprise Value/Ebitda3.49
Forecast
1Y Price Target
$5.25Price Target Upside71.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.2
Revenue Forecast (FY)$130.94M
CareCloud Business Overview & Revenue Model
Company Description
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcar...
How the Company Makes Money
CareCloud generates revenue primarily by selling healthcare software and by providing recurring, outsourced services to provider organizations. Key revenue streams include: (1) Subscription/SaaS and software-related revenue: recurring fees for acc...
CareCloud Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The call presented a broadly positive operational and strategic picture: double-digit revenue growth (13% Y/Y), commercialization and scaling of AI products (StratusAI handling ~75% of inbound calls for early adopters), successful capital structure simplification (new $50M facility and Series B redemption with no common dilution), and reaffirmation of full-year guidance with a forecasted >100% EPS improvement versus 2025. Offsetting these positives are near-term integration and amortization headwinds from the Medsphere acquisition, a drop in free cash flow and modest declines in certain adjusted metrics; management expects margins and cash generation to improve as integration and amortization effects subside and AI and cross-sell synergies ramp in the back half of the year. On balance, the call conveys momentum and clear strategic progress despite expected short-term integration costs.Positive Updates
Revenue Growth
Total revenue of $31.3 million in Q1 2026, up 13% from $27.6 million in Q1 2025.
Negative Updates
GAAP Net Income Decline vs Prior Year
Q1 2026 GAAP net income of $922,000 declined from $1.9 million in Q1 2025, primarily driven by increased amortization of acquired intangible assets and integration/transitional costs from the Medsphere acquisition.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth
Total revenue of $31.3 million in Q1 2026, up 13% from $27.6 million in Q1 2025.
Read all positive updates
Company Guidance
CareCloud reaffirmed full-year 2026 guidance calling for revenue of $128.0–$132.0 million, adjusted EBITDA of $29.0–$31.0 million and GAAP EPS of $0.20–$0.23 (more than a 100% increase versus 2025 EPS of $0.10). In Q1 the company delivered $31.3 million of revenue (up 13% year-over-year from $27.6M), GAAP operating income of ~$1.0M and GAAP net income of ~$0.9M (its eighth consecutive quarter of positive GAAP net income), adjusted EBITDA of $5.4M (17% of revenue), adjusted net income of $2.2M or $0.05 per share, and $2.4M of free cash flow; the balance sheet included ~$3.9M of cash and $2.6M of net working capital as of March 31. Management also highlighted capital moves that de-risk the outlook: a new $50M credit facility ($40M term loan / $10M revolver), an ATM equity facility for optionality, and a fully funded (~$41.6M) redemption of Series B preferred stock scheduled for May 15; on the product side they noted that stratusAI Front Desk targets a U.S. addressable market exceeding $4 billion.CareCloud Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
78
Positive
Cash Flow
81
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.14M | 120.50M | 110.84M | 117.06M | 138.83M | 139.60M |
| Gross Profit | 39.30M | 56.04M | 49.99M | 46.24M | 54.39M | 52.68M |
| EBITDA | 28.33M | 28.26M | 25.05M | -31.29M | 21.02M | 19.70M |
| Net Income | 9.77M | 10.80M | 7.85M | -48.67M | 5.43M | 2.84M |
Balance Sheet | ||||||
| Total Assets | 86.72M | 87.60M | 71.61M | 77.83M | 136.17M | 140.85M |
| Cash, Cash Equivalents and Short-Term Investments | 3.85M | 3.12M | 5.14M | 3.33M | 12.30M | 9.34M |
| Total Debt | 5.74M | 4.28M | 3.47M | 14.73M | 13.81M | 16.87M |
| Total Liabilities | 28.39M | 28.09M | 21.84M | 36.11M | 34.48M | 42.92M |
| Stockholders Equity | 58.33M | 59.51M | 49.77M | 41.72M | 101.69M | 97.93M |
Cash Flow | ||||||
| Free Cash Flow | 27.27M | 23.78M | 18.95M | 3.85M | 9.38M | 2.77M |
| Operating Cash Flow | 27.06M | 28.56M | 20.64M | 15.46M | 21.15M | 13.33M |
| Investing Cash Flow | -24.26M | -24.54M | -7.41M | -11.61M | -11.77M | -23.15M |
| Financing Cash Flow | -5.83M | -5.61M | -11.26M | -13.29M | -7.65M | -519.00K |
CareCloud Technical Analysis
Negative
3.07
Price Trends
2.99
Negative
2.84
Negative
3.02
Negative
Market Momentum
-0.22
Positive
37.52
Neutral
70.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Negative. The current price of 3.07 is above the 20-day moving average (MA) of 2.56, above the 50-day MA of 2.99, and above the 200-day MA of 3.02, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 37.52 is Neutral, neither overbought nor oversold. The STOCH value of 70.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCLD.
CareCloud Risk Analysis
CareCloud disclosed 73 risk factors in its most recent earnings report. CareCloud reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
CareCloud Peers Comparison
UnderperformOutperform
Sector (51)
CCLD
CareCloud
2.28
0.29
14.57%
AMWL
American Well
7.96
0.97
13.88%
ONMD
OneMedNet
0.90
0.49
120.24%
BEAT
HeartBeam
0.88
-0.73
-45.47%
EUDA
EUDA Health Holdings
17.36
-57.84
-76.91%
CareCloud Corporate Events
Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance
CareCloud fully redeems and delists Series B preferred
Neutral
May 15, 2026
CareCloud, Inc. redeemed and delisted its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock in May 2026, while keeping its common stock listed on the Nasdaq Global Market under the symbol CCLD. The Series B preferred shares were delis...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
CareCloud posts Q1 results, expands AI healthcare offerings
Positive
May 7, 2026
On May 7, 2026, CareCloud reported first-quarter 2026 results showing revenue of $31.3 million, up 13% year over year from $27.6 million, alongside its eighth consecutive quarter of positive GAAP net income, though profit dipped to $922,000 from $...
Business Operations and StrategyDelistings and Listing ChangesPrivate Placements and Financing
CareCloud Simplifies Capital Structure with Preferred Stock Redemption
Positive
Apr 14, 2026
On April 13, 2026, CareCloud, Inc. closed a $50 million credit facility with Citizens Bank and Provident Bank, comprising a $40 million term loan and a $10 million revolver, both maturing four years after closing. The facility, secured by substant...
Business Operations and Strategy
CareCloud Updates Bylaws, Modifies Shareholder Quorum Requirements
Neutral
Apr 2, 2026
On April 2, 2026, CareCloud’s board of directors approved and adopted an amendment to the company’s bylaws that took effect immediately. The change specifically modifies the quorum requirement for meetings of stockholders, potentially ...
Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresRegulatory Filings and Compliance
CareCloud Director Resignation Supports Nasdaq Governance Compliance
Neutral
Mar 12, 2026
On March 10, 2026, CareCloud, Inc. announced that director A. Hadi Chaudhry resigned from its Board of Directors, effective immediately, to help the company regain compliance with Nasdaq’s director independence rule requiring a majority-inde...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.